In a trial [40] comparing formoterol and indacaterol the latter at 300 mcg OD provided a greater effect on bronchial obstruction and LH than the former at usual dose of 12 mcg BID in patients with COPD. This evidence concerns the gene PLOD1 and chronic obstructive pulmonary disease.